NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine -

Tags: asthma


Could an expensive chemotherapy drug treat severe asthma? It’s too soon to know


Hookworms for asthma: Washington Post oversells preliminary research


The Guardian’s look at an inhaler to protect lungs from air pollution borders on puffery


In just a few short paragraphs, Reuters story covers a lot of ground on asthma pill


‘Game changer’ finds it way into poorly reported story on asthma pill still in development


New Drug May Help Some Asthmatics, Study Finds

1 5/24/2013

Regeneron, Sanofi asthma drug seen as potential game changer

1 9/5/2012

Relief for Severe Asthma, at a High Price

1 3/6/2012

Can Herbs Fight Asthma?


New Surgery to Treat Asthma